Stocks Comparison
Alcon vs RxSight: revenue, profit, margins and growth compared
Alcon brought in $10.4B of revenue in fiscal 2025, RxSight $134.5M in fiscal 2025. Revenue changed by +4.9% at Alcon and -3.9% at RxSight on the year before, so Alcon grew faster. Alcon kept 9.4% of its revenue as net profit, RxSight -29.0%. Free cash flow was $1.7B at Alcon and -$19.3M at RxSight.
Side by side, latest fiscal year
| ALC | RXST | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $10.4B | $134.5M |
| Revenue growth | +4.9% | -3.9% |
| Net income | $980M | -$38.9M |
| Net margin | 9.4% | -29.0% |
| Free cash flow | $1.7B | -$19.3M |
| Free cash flow margin | 16.6% | -14.4% |
| Earnings per share (diluted) | $1.98 | -$0.95 |
| Cash | $1.5B | $19.9M |
| Debt | $4.7B | n/a |
| Price to earnings | n/a | n/a |
| Market value | $32.2B | $193.8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #44 of 523 · Health care | #279 of 523 · Health care |
Over the years
Questions about Alcon and RxSight
Which is bigger by revenue, Alcon or RxSight?
Alcon is bigger by revenue: $10.4B in fiscal 2025, against $134.5M for RxSight in fiscal 2025.
Which keeps more of its revenue as profit, Alcon or RxSight?
Alcon had a net margin of 9.4% in fiscal 2025; RxSight had -29.0% in fiscal 2025.
Which grew revenue faster, Alcon or RxSight?
In their latest fiscal years revenue changed by +4.9% at Alcon and -3.9% at RxSight.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.